Comparison of Glycemic Variability and Hypoglycemic Events in Hospitalized Older Adults Treated with Basal Insulin plus Vildagliptin and Basal–Bolus Insulin Regimen: A Prospective Randomized Study
Authors:
- Sol BatuleSBSol Batule
- Analía RamosARAnalía Ramos
- Alejandra Pérez-Montes de OcaAOAlejandra Pérez-Montes de Oca
- Natalia FuentesNFNatalia Fuentes
- Santiago MartínezSMSantiago Martínez
- Joan RagaJRJoan Raga
- Xoel PenaXPXoel Pena
- Cristina TuralCTCristina Tural
- Pilar MuñozPMPilar Muñoz
- Berta SoldevilaBSBerta Soldevila
- Nuria AlonsoNANuria Alonso
- Guillermo UmpierrezGUGuillermo Umpierrez
Open Access
- 16 May 2022
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (10) , 2813
Abstract
Background: The basal–bolus insulin regimen is recommended in hospitalized patients with diabetes mellitus (DM), but has an increased risk of hypoglycemia. We aimed to compare dipeptidyl peptidase 4 inhibitors (DPP4-i) and basal–bolus insulin glycemic outcomes in hospitalized type 2 DM patients. Methods and patients: Our prospective randomized study included 102 elderly T2DM patients (82 ± 9 years, HbA1c 6.6% ± 1.9). Glycemic control: A variability coefficient assessed by continuous glucose monitoring (Free Style® sensor), mean insulin dose and hypoglycemia rates obtained with the two treatments were analyzed. Results: No differences were found between groups in glycemic control (mean daily glycemia during the first 10 days: 152.6 ± 38.5 vs. 154.2 ± 26.3 mg/dL; p = 0.8). The total doses Kg/day were 0.40 vs. 0.20, respectively (p < 0.001). A lower number of hypoglycemic events (9% vs. 15%; p < 0.04) and lower glycemic coefficient of variation (22% vs. 28%; p < 0.0002) were observed in the basal–DPP4-i compared to the basal–bolus regimen group. Conclusions: Treatment of inpatient hyperglycemia with basal insulin plus DPP4-i is an effective and safe regimen in old subjects with T2DM, with a similar mean daily glucose concentration, but lower glycemic variability and fewer hypoglycemic episodes compared to the basal bolus insulin regimen.Keywords
This publication has 22 references indexed in Scilit:
- Hypoglycemia: The neglected complicationIndian Journal of Endocrinology and Metabolism, 2013
- Glycemic Variability in Hospitalized Patients: Choosing Metrics While Awaiting the EvidenceCurrent Diabetes Reports, 2012
- Evidence That Hyperglycemia After Recovery From Hypoglycemia Worsens Endothelial Function and Increases Oxidative Stress and Inflammation in Healthy Control Subjects and Subjects With Type 1 DiabetesDiabetes, 2012
- Clinical Interpretation of Indices of Quality of Glycemic Control and Glycemic VariabilityPostgraduate Medicine, 2011
- Randomized Study of Basal-Bolus Insulin Therapy in the Inpatient Management of Patients With Type 2 Diabetes Undergoing General Surgery (RABBIT 2 Surgery)Diabetes Care, 2011
- Clinical experience with vildagliptin in the management of type 2 diabetes in a patient population ≥75 years: a pooled analysis from a database of clinical trialsDiabetes, Obesity and Metabolism, 2010
- AACE/ADA Consensus StatementEndocrine Practice, 2009
- Glycemic Variability: The Third Component of the Dysglycemia in Diabetes. Is it Important? How to Measure it?Journal of Diabetes Science and Technology, 2008
- Variability of Blood Glucose Concentration and Short-term Mortality in Critically Ill PatientsAnesthesiology, 2006
- Management of Diabetes and Hyperglycemia in HospitalsDiabetes Care, 2004